Terminal Procedure

Endpoint planning determines which measurements must be collected at the experiment’s conclusion and helps align euthanasia, sampling, and analysis with the study question. A clearly defined endpoint can connect treatment exposure with physiological, cellular, or pathological changes. It also supports consistent handling across subjects, reducing variation that could complicate interpretation or weaken reproducibility.

The method must be appropriate for the species and selected to minimize pain and distress while preserving the measurements required by the study. Because terminal sampling follows euthanasia, the approved approach becomes part of the experimental design rather than an isolated welfare decision. Consistency in that approach helps researchers compare endpoint findings across subjects and experiments.

Some endpoint measurements require access to organs, tissues, or blood that cannot be obtained fully from a living subject. A terminal procedure therefore permits broader examination of internal biological effects, including histology, molecular assays, and biochemical analysis. In contrast, nonterminal observations can support repeated or longitudinal assessment but may not provide the same tissue-level information.

The process begins with an approved experimental endpoint and a species-appropriate method for humane euthanasia. Once the endpoint is reached, researchers obtain the planned blood, organs, or tissues and direct them toward analyses such as histology, molecular assays, or biochemical testing. Following a predefined sequence helps preserve study consistency and links each specimen to the intended outcome.

Blood, organs, and tissue may be collected according to the study’s endpoint measurements. Histology can support examination of tissue structure, while molecular assays and biochemical analysis provide other levels of biological information. Selecting samples that match the research question allows investigators to relate treatment exposure to physiological, cellular, or pathological outcomes rather than relying on a single measurement.

They are especially useful when researchers need integrated endpoint evidence about how an intervention affects an organism. Samples collected at the end of a study can connect exposure with physiological responses and cellular or pathological findings, supporting preclinical evaluation. Approved endpoints, humane methods, and consistent sampling also contribute to ethical study design, regulatory oversight, and reproducible results.